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Background: To describe local or systemic complications related to the labial salivary glands biopsy (LSGB) used 
as diagnostic tool for the diagnosis of Sjögren’s Syndrome (SS).
Material and Methods: Clinical databases from a cohort of patients, who underwent LSGB with provisional cli-
nical diagnosis of Sjögren’s Syndrome, were retrospectively reviewed. Pain, assessed by registering the intake 
of analgesic drugs in the first week following the biopsy, and any further relevant clinical information regarding 
complications after biopsy were recorded.
Results: 50 patients received LSGB. 10 of them (9 women and 1 man) showed histopathological findings compati-
ble with SS. Ten patient (20%) receiving labial biopsy developed local complications: three of them (6%) reported 
a sensory defect at the surgical site that lasted at most few weeks; three patients (6%) reported pain sensation nee-
ding the assumption of analgesic drugs, while one patient (2%) described a transient local burning sensation, which 
resolved in few days. Three patients (6%) showed cutaneous haematoma in the surgical area and two patients (4%) 
showed mild mucosal inflammation at the biopsy site.
Conclusions: LSGB is associated with to few and mild complications and it is a useful tool in the diagnosis of SS. 
The complications usually resolved in few weeks after the biopsy. 




Sjögren’s Syndrome (SS) is a chronic, autoimmune, 
rheumatic disease characterized by the lymphocytic-me-
diated destruction of exocrine glands, resulting in glan-
dular dysfunction (1). It affects mainly Caucasian fema-
les, at age of 40-50 years (2).
SS is typically characterized by xerostomia and xero-
phthalmia (“sicca syndrome”), due to reduced glandular 
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secretions. SS is also regarded as a multisystem disease, 
since can affect other organs, such as lung, kidneys, skin 
(1). In case of just secretory glands involvement, thus 
without the concomitant occurrence of further chronic 
inflammatory autoimmune disorders, this syndrome is 
known as primary Sjögren’s syndrome (pSS), while, 
when in association with other systemic connective tis-
sue diseases, it is known as secondary Sjögren’s syndro-
me (sSS) (3). 
Among oral symptoms, besides xerostomia, patients with 
SS usually complain dysgeusia, oral burning sensation, 
difficulty in swallowing food, problems in using remova-
ble dental prosthesis. These patients are also at high risk 
of dental caries (4) and oral candidiasis infections (5). 
All together, these signs and symptoms strongly decrea-
se the health-related quality of life of SS patients, with 
important impact on the emotional and psychological 
spheres (6). Furthermore, epidemiological data empha-
sized their higher risk of developing a mucosal-associa-
ted lymphoid tissue (MALT) lymphoma (7). 
The final diagnosis of SS is complex and multi-steps; 
it is chiefly achieved by rheumatologists, in teamwork 
with ophthalmologists and oral medicine/pathology 
specialists. In 2016, the American College of Rheuma-
tology and the European League Against Rheumatism 
developed and validated an updated set of classification 
criteria, based on the weighted sum of the following 5 
items (Table 1): anti-SSA/Ro antibody positivity, fo-
Item Score
Labial salivary gland biopsy (LSGB)* 3
Anti-SSA/Ro positive 3
Ocular Staining Score Ϯ 1
Schirmer’s test Ψ 1
Reduced unstimulated whole saliva flow χ 1
Table 1: The classification criteria for SS, modified from Shiboski 
2017 (1).
*Labial salivary gland with focal lymphocytic sialadenitis and 
focus score of ≥ 1 foci/4 mm2 
Ϯ Ocular Staining Score ≥5 (or van Bijsterveld score ≥4) in at least 
1 eye
Ψ Schirmer’s test ≤ 5 mm/5 minutes in at least 1 eye 
χ rate: ≤ 0.1 ml/minute 
cal lymphocytic sialadenitis, abnormal ocular staining 
score, reduced Schirmer’s test, and reduced unstimu-
lated salivary flow rate (1). Individuals with signs and/
or symptoms suggestive of SS with a score higher than 
4 for the above items meet the criteria for primary SS, 
with excellent sensitivity and specificity.
Focal lymphocytic sialadenitis needs to be assessed with 
Labial Salivary Gland Biopsy (LSGB), which allows to 
detect the occurrence of dense aggregates (foci) of ≥50 
mononuclear cells (mostly lymphocytes), localized at a 
periductal or perivascular level (8). LSGB in the diagno-
sis of SS plays a keystone role and it is widely applied 
in the clinical settings. In the last decades, some Authors 
also suggested the use of parotid gland as the organ of 
choice for investigating salivary gland involvement in 
SS, since major salivary glands, especially parotids, 
could be earlier and more frequently involved than the 
minor ones (7). Although parotid biopsy shows compa-
rable sensibility and specificity to LSGB, it requires a 
more experienced operator. Parotid biopsy’s potential 
complications include facial nerve damage, cutaneous 
fistulae, scarring, or temporary change in sensory sensa-
tion of the skin in the area of the incision (9-11). To date, 
just few centers use this technique.
The aim of this study was to evaluate local complica-
tions of LSGB used in the diagnostic algorithm of SS.
Material and Methods
-Study design, population and setting 
In this observational cohort study, we retrospectively re-
viewed the clinical databases of patients who underwent 
LSGB, at Unità di Medicina Orale (San Paolo Hospi-
tal, Milan, Italy). For all of them the provisional clinical 
diagnosis was Sjögren’s Syndrome. 50 patients were en-
rolled, in a consecutive order and without any exclusion 
criteria, over a period of 36 months from 2015 to 2018. 
None salivary gland biopsy was previously performed 
on these patients. 
Each patient had signed two informed consents: the first 
one was related to privacy and data collection while the 
second one was related to the bioptic surgical procedure. 
-Surgical procedure
After written informed consent, in all cases, the LSGB 
included a preliminary oral rinse with 0.2% chlorhexidi-
ne, then local anesthesia was performed by infiltration of 
2% mepivacaine with vasoconstrictor (1:200.000 adre-
nalin); a single horizontal incision of about 1 – 1.5 cm of 
length between the midline and commissure of the lower 
labial mucosa was carried out, on clinically healthy la-
bial mucosa. After removal of minor salivary glands, the 
surgical flaps were closed by black silk suture 4/0. 
At the end of each biopsy, the patient received detailed 
post-surgical indications recommending to apply topical 
1% chlorhexidine gel (twice a day for 7 days), not to 
smoke for at least 7 days and to avoid hot foods for 48 
hours.
The suture was removed seven days after the surgical 
procedure, when local complications were recorded du-
ring the clinical evaluation.
-Data collection
The complete clinical history of each patient, including 
systemic diseases, pharmacological therapies and demo-
graphic data, was recorded. 
Sialometry, as clinical step during diagnostic assess-
ment, was also recorded for each patient, to verify the 
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flow rate of the whole saliva (normal values: 0.2-0.5 ml/
min), both unstimulated and stimulated by spitting me-
thod (12). When available, results from the Schirmer’s 
test, performed by the ophthalmologist to verify xeroph-
thalmia, were further collected.
Reported pain, assessed by registering the intake of anal-
gesic drugs in the first week following the biopsy, was 
recorded, as any further relevant information regarding 
post-operative complications.
Statistical analysis
-Data were analyzed by means of descriptive statistics. 
Age was expressed as mean and standard deviation 
(mean ± SD). Prevalence of complication was expressed 
as percentage (%).
Results
Data from 50 patients were reviewed. They were 45 
women and 5 men (female: male ratio = 9 :1), with 
a mean age of 56.1±14.4 years (range 24-85). 17 of 
them had at least one systemic autoimmune disease 
that was already diagnosed (2 patients were affected 
by other two concomitant autoimmune disease) (Table 
2, 2 cont.). Eight patients had xerostomia objectively 
confirmed by sialometry; in 6 patients the Schirmer’s 
test was also positive. No patient needed the assump-
tion of antibiotics after the LSGB. All specimens ob-
tained by biopsy were adequate for histopathological 
analysis. Of the 50 patients biopsied, one received the 
final diagnosis of Mikulicz’s disease (MD), while 10 
Patients Sex Age Autoimmune disease Complications Histopathological 
findings compatible 
with SS
1 F 60 RA N
2 F 34 N
3 F 63 N
4 F 63 P
5 F 67 PSS / RA BS SS
6 F 72 H SS
7 F 31 SLE N
8 F 24 N
9 M 85 N
10 F 52 CTD N
11 F 40 N
12 F 37 N SS
13 F 68 N
14 F 48 N
15 F 52 HT N
16 F 52 N
17 F 63 N MD
18 F 66 HT N
19 F 60 N
20 F 54 MI
21 F 48 N
22 M 43 N
23 F 45 RA N SS
24 F 60 P / SD
25 M 70 N
26 F 48 N
27 F 31 SLE N
28 F 37 P
29 F 70 N
Table 2: Demographic data, clinical findings and post-surgical complications in 50 patients who under-
went labial salivary gland biopsy (LSGB).
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30 F 64 RA N
31 F 74 PSS N
32 M 42 N SS
33 F 71 N
34 F 63 PSS N
35 F 69 N
36 F 52 N
37 F 64 RA / PBC N SS
38 F 36 SD
39 F 61 N SS
40 F 52 RA MI / SD
41 F 66 N SS
42 F 65 N
43 F 62 PBC H
44 F 66 PBC N
45 F 32 CTD N
46 F 68 N SS
47 F 71 RA N SS
48 F 82 H
49 M 38 N
50 F 68 N
Table 2 cont.: Demographic data, clinical findings and post-surgical complications in 50 patients who 
underwent labial salivary gland biopsy (LSGB).
Patients Sex Age Autoimmune disease Complications Histopathological 
findings compatible 
with SS
RA, rheumatoid arthritis; PSS, progressive systemic sclerosis; PBC, primary biliary cirrhosis; CTD, 
connective tissue disease; HT, Hashimoto’s thyroiditis; SLE, systemic lupus erythematosus; N, none; 
BS, burning sensation; P, pain; H, haematoma; SD, sensory defect; MI, mild inflammation; SS, Sjogren’s 
syndrome; MD, Mikulicz’s disease.
patients (9 women and 1 man) had histopathological 
findings compatible with SS.
Ten of the total 50 patients (20%) receiving labial biopsy 
developed local complications (Table 3).  Three patients 
(6%) reported temporarily local dysesthesia; the latter 
was localized to a small area of the labial mucosa and 
lasted few weeks and was followed by a higher sensa-
tion than normal. In all cases completely normal sensa-
tion was recovered in few months. Further three patients 
(6%) reported a pain needing the assumption of an anal-
gesic drug, which resolved within 2 days after biopsy; 
one patient (2%) described a transient local burning 
sensation, not requiring any drug intake. Three patients 
(6%) showed cutaneous haematoma in correspondence 
of surgical intervention, while two patients (4%) showed 
mild mucosal inflammation at the biopsy site. Only two 
of the patients, who developed temporarily local dyses-
thesia, reported the concomitant presence of a second 
local complication: mild inflammation in the first case 
and pain in the second one. 
Two patients with post-operative complications were 
positive for SS (one reporting burning sensation, while 
one hematoma).
Discussion
LSGB is a useful and easy method to investigate salivary 
gland involvement in patient with suspected SS (9,13-
Local complications
Sensory defect 3 (6%)
Pain 3 (6%)
Haematoma 3 (6%)
Mild inflammation 2 (4%)
Burning sensation 1 (2%)
Table 3: Complications associated with LSGB 
procedure for diagnosis of Sjogren’s Syndrome 
(n=50 patients). Two patients reported more than 
one complication, developing transient local dys-
esthesia in association with mild inflammation, in 
one case, and with pain in the other case”
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15). In this study, all the specimens were, indeed, con-
sidered sufficient for the diagnosis by pathologists. Lip 
biopsy can quickly be performed with minimal discom-
fort for the patient because glands are widely distribu-
ted, they have an easy access, and can provide adequate 
tissue sample for histopathological analysis (9). A focus 
score ≥1 foci/4 mm2 on LSGB is one of the European 
classification criteria for the diagnosis of pSS (Table 1). 
Although not uncommon (ten patients in our cohort of 50 
patients: 20%), in the present study local complications 
of LSGB, recorded 7 days after the biopsy, were just of 
minor entity, without long-term sequelae. Therapy, when 
required, involved the local application of antiseptic agent 
(chlorhexidine) for a period longer than 1 week or the as-
sumption of analgesic drugs. Other studies showed even 
lower percentage of short- and medium-term complica-
tions, with rates ranging from 8.1% (16) to 11.5% (17).
One of the mostly reported complication was a reduced 
sensitivity over a small area of labial mucosa at biopsy site 
(3 patients out of 50: 6%), a complication that encounte-
red also in the surgical treatment of labial mucoceles (18). 
The sensory disturbances lasted from few weeks until few 
months, and usually did not cause difficulty or distress, as 
long as the patient was informed about this specific ad-
verse event, before performing the biopsy. Partial loss of 
lip sensitivity was recorded also by other Authors after 
LSGB: 2 patients out of 58 (3.4%) reported by Richards 
et al. (14); 3 patients out of 362 (1.1%) by Daniels and 
colleagues (15) and 3 patients out of 79 (3.8%) recorded 
by Marx et al. (7). A retrospective analysis (17) described 
the lip paraesthesia, in the first week after LSGB, in 8.2% 
(n=452) of patients; after 7 days, 3.5% of these patients 
still had paraesthesia which resolved in few weeks, and 
only one of them (0.2%) had a long-term paraesthesia. 
The complete normal sensitivity is usually restored wi-
thin a few weeks, although long-lasting impaired sensory 
defects have been rarely reported. Richards et al. (14) des-
cribed one case of sensory defect that persisted for more 
than one year, while another study (7) showed one patient 
with anaesthesia persisting for more than 2 years. A com-
parative study, comparing LSGB and sublingual salivary 
gland biopsy, reported one case of permanent anaesthesia 
after LSGB (19). 
Pain was a further reported complication, in our study 
occurring in 3 patients (6%) and lasting maximum for 2 
days. Pain was easily controlled by the intake of analge-
sic drugs as NSAIDs. Most of literature showed similar 
findings: Friedman et al. (20) reported only one case out 
118 patients (0.8%) of pain immediately after the biopsy, 
and 3 cases (2.5%) after one week. In the study by Li-
da-Santiago et al. (16) involving 186 individuals, 12 pa-
tients (7.32%) still had pain after 7 days, lasting at most 1 
month. Only one study reported a higher percentage (11): 
11 patients out of 35 (31%) experienced some pain after 
the biopsy, which resolved in all cases within in month.
Furthermore, some cases of cutaneous haematoma (3 pa-
tients out of 50: 6%) and mild inflammation (2 patients 
out of 50: 4%) at the biopsy site were recorded. These 
side-effects were always of small entity, and healed in a 
few days spontaneously. These signs were reported also 
by other authors (15-17), with similar clinical course. 
One third of the patients included in the study (17 out of 
50 patients: 34%) showed at least one additional autoim-
mune disease, reported in the following list: rheumatoid 
arthritis (RA), progressive systemic sclerosis (PSS), pri-
mary biliary cirrhosis (PBC), connective tissue disease 
(CTD), Hashimoto’s thyroiditis (HT), systemic lupus 
erythematosus (SLE).
Among the ten patients who developed post-operative 
complications only three of them were affected by other 
autoimmune diseases: progressive systemic sclerosis 
and rheumatoid arthritis in the first case, primary biliary 
cirrhosis in the second one and rheumatoid arthritis in 
the third case. 
Other very rare complications found in literature were 
pyogenic granuloma, with prevalence varying from 
0.5% (21) to 1.22% of cases (16), suture failure in 3.4% 
(20), local swelling in 24 patients out of 452 (5.3%) (17) 
and syncope in 6 patients out of 186 (3.2%) (16). On 
the other hand, some Authors did not report any com-
plication after LSGB, except for mild discomfort at the 
biopsy site lasting up to one week (10). A specific infor-
med consent before performing the surgical procedure is 
always recommended in order to minimize the patients’ 
distress in case of post-operative complications.
Within the limitations of this work, which are mainly 
related to the retrospective approach of this study, to the 
small size of the sample and to the surgical procedures 
performed by different oral surgeons with variable cli-
nical experience, this cohort study confirms that LSGB 
is an easy and useful tool for the diagnosis of SS. This 
diagnostic method, compared to the more invasive and 
risky parotid gland biopsy, it’s associated with minor 
complications. When occurring, they are mostly mild 
and can be resolved within few weeks. The biopsy of 
the lip is usually well-accepted by patients perceiving 
this technique as minimally invasive, with a low risk of 
complications. 
In conclusion, this work confirms that, consistently with 
previous literature, LSGB is a useful tool for the diag-
nosis of SS, since it is mainly associated with reliable 
accuracy and minor local complications.
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